PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT 2.1 Preface 2.2 Preface 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE Market ecosystem Market characteristics Market segmentation analysis PART 04: MARKET SIZING Market definition Market sizing 2018 Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition PART 06: MARKET SEGMENTATION BY PRODUCT Market segmentation by product Comparison by product LVPs and syringe pumps - Market size and forecast 2018-2023 Elastomeric pumps - Market size and forecast 2018-2023 Market opportunity by product PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE Geographic segmentation Geographic comparison North America - Market size and forecast 2018-2023 Europe - Market size and forecast 2018-2023 Asia - Market size and forecast 2018-2023 ROW - Market size and forecast 2018-2023 Key leading countries Market opportunity PART 09: DECISION FRAMEWORK PART 10: DRIVERS AND CHALLENGES Market drivers Market challenges PART 11: MARKET TRENDS Increasing adoption of chemotherapy infusion pumps in homecare and ambulatory settings Growing adoption of disposable chemotherapy infusion pumps Advent of smart infusion pumps for chemotherapy administration PART 12: VENDOR LANDSCAPE Overview Landscape disruption Competitive scenario PART 13: VENDOR ANALYSIS Vendors covered Vendor classification Market positioning of vendors B. Braun Melsungen AG Baxter International Inc. Becton Dickinson and Co. ICU Medical Inc. Smiths Group Plc PART 14: APPENDIX Research methodology List of abbreviations Definition of market positioning of vendors PART 15: EXPLORE TECHNAVIO   Exhibit 01: Global medical devices market Exhibit 02: Segments of global medical devices market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2018 Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 08: Global market: Year-over-year growth 2019-2023 (%) Exhibit 09: Five forces analysis 2018 Exhibit 10: Five forces analysis 2023 Exhibit 11: Bargaining power of buyers Exhibit 12: Bargaining power of suppliers Exhibit 13: Threat of new entrants Exhibit 14: Threat of substitutes Exhibit 15: Threat of rivalry Exhibit 16: Market condition - Five forces 2018 Exhibit 17: Product - Market share 2018-2023 (%) Exhibit 18: Comparison by product Exhibit 19: LVPs and syringe pumps - Market size and forecast 2018-2023 ($ millions) Exhibit 20: LVPs and syringe pumps - Year-over-year growth 2019-2023 (%) Exhibit 21: Elastomeric pumps - Market size and forecast 2018-2023 ($ millions) Exhibit 22: Elastomeric pumps - Year-over-year growth 2019-2023 (%) Exhibit 23: Market opportunity by product Exhibit 24: Customer landscape Exhibit 25: Market share by geography 2018-2023 (%) Exhibit 26: Geographic comparison Exhibit 27: Malignant neoplasms of colon and lungs in few North American countries 2012 (Incidence rate per 100,000 population) Exhibit 28: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 29: North America - Year-over-year growth 2019-2023 (%) Exhibit 30: Estimated number of hospital discharge rates of in-patients treated with neoplasms in few European countries 2016 (per 100,000 population) Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 32: Europe - Year-over-year growth 2019-2023 (%) Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 34: Asia - Year-over-year growth 2019-2023 (%) Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 36: ROW - Year-over-year growth 2019-2023 (%) Exhibit 37: Key leading countries Exhibit 38: Market opportunity Exhibit 39: Product launch details and market impact analysis Exhibit 40: M&A and their market impact analysis Exhibit 41: Product discontinuation: Overview Exhibit 42: Product recalls: Overview Exhibit 43: Impact of drivers and challenges Exhibit 44: Vendor landscape Exhibit 45: Landscape disruption Exhibit 46: Vendors covered Exhibit 47: Vendor classification Exhibit 48: Market positioning of vendors Exhibit 49: B. Braun Melsungen AG - Vendor overview Exhibit 50: B. Braun Melsungen AG - Business segments Exhibit 51: B. Braun Melsungen AG - Organizational developments Exhibit 52: B. Braun Melsungen AG - Geographic focus Exhibit 53: B. Braun Melsungen AG - Segment focus Exhibit 54: B. Braun Melsungen AG - Key offerings Exhibit 55: B. Braun Melsungen AG - Key customers Exhibit 56: Baxter International Inc. - Vendor overview Exhibit 57: Baxter International Inc. - Business segments Exhibit 58: Baxter International Inc. - Organizational developments Exhibit 59: Baxter International Inc. - Geographic focus Exhibit 60: Baxter International Inc. - Segment focus Exhibit 61: Baxter International Inc. - Key offerings Exhibit 62: Baxter International Inc. - Key customers Exhibit 63: Becton Dickinson and Co. - Vendor overview Exhibit 64: Becton Dickinson and Co. - Business segments Exhibit 65: Becton Dickinson and Co. - Organizational developments Exhibit 66: Becton Dickinson and Co. - Geographic focus Exhibit 67: Becton Dickinson and Co. - Segment focus Exhibit 68: Becton Dickinson and Co. - Key offerings Exhibit 69: Becton Dickinson and Co. - Key customers Exhibit 70: ICU Medical Inc. - Vendor overview Exhibit 71: ICU Medical Inc. - Business segments Exhibit 72: ICU Medical Inc. - Organizational developments Exhibit 73: ICU Medical Inc. - Geographic focus Exhibit 74: ICU Medical Inc. - Segment focus Exhibit 75: ICU Medical Inc. - Key offerings Exhibit 76: ICU Medical Inc. - Key customers Exhibit 77: Smiths Group Plc - Vendor overview Exhibit 78: Smiths Group Plc - Business segments Exhibit 79: Smiths Group Plc - Organizational developments Exhibit 80: Smiths Group Plc - Geographic focus Exhibit 81: Smiths Group Plc - Segment focus Exhibit 82: Smiths Group Plc - Key offerings Exhibit 83: Smiths Group Plc - Key customers Exhibit 84: Validation techniques employed for market sizing Exhibit 85: Definition of market positioning of vendors  

B. Braun Melsungen AG Baxter International Inc. Becton Dickinson and Co. ICU Medical Inc. Smiths Group Plc